Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health CarelonRx — GAAP Operating Margin by Year
CarelonRx — GAAP Operating Margin (%) (%)
Elevance Health CarelonRx — GAAP Operating Margin: 5.6% in FY2025, down 0.4 pts from a year earlier.
Latest, FY2025
5.6%
Period ended Dec 31, 2025
Change on a year earlier
-0.4 pts
6.0% in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| CarelonRx | 6.2 | % | 5.3 | % | 90 bp | 5.6 | % | 6.0 | % | (40) bp”
Source: 8-K ER (FY2025Q4, 2026-01-28) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx — GAAP Operating Margin (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.6% | -0.4 pts | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2024 | Dec 31, 2024 | 6.0% | +0.2 pts | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2023 | Dec 31, 2023 | 5.8% | -0.8 pts | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| FY2022 | Dec 31, 2022 | 6.6% | +16.6 pts | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| FY2021 | Dec 31, 2021 | -10.0% | -16.2 pts | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| FY2020 | Dec 31, 2020 | 6.2% | 0.0 pts | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 6.2% | – | 8-K ER (FY2020Q4, 2021-01-27) ↗ |
Cite this data
StockData. (2026). Elevance Health CarelonRx — GAAP Operating Margin (%), annual FY2019–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-margin-carelonrx
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.